Alicia Pierse
Hospitalist · Baytown, TXNPI 1881345452
Payments from drug & device makers
Across 73 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$281
- Daiichi Sankyo Inc.$124
- Novartis$121
- Stemline Therapeutics Inc.$120
- Bristol Myers Squibb$103
- Sobi, Inc$103
- plus $841 from 19 others
What the payments were for
- Food & beverage$1,60895%
- Education$855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 14 | $281 |
| Daiichi Sankyo Inc. | 6 | $124 |
| Novartis | 6 | $121 |
| Stemline Therapeutics Inc. | 1 | $120 |
| Bristol Myers Squibb | 5 | $103 |
| Sobi, Inc | 2 | $103 |
| Amgen | 5 | $100 |
| CTI Biopharma Corp. | 4 | $89 |
| AVEO Pharmaceuticals, Inc. | 3 | $82 |
| GSK | 3 | $82 |
| Merck | 3 | $74 |
| Tersera Therapeutics LLC | 2 | $53 |
| Pharmaessentia USA Corporation | 2 | $50 |
| Taiho Oncology, Inc. | 3 | $46 |
| Shield Therapeutics Inc | 2 | $41 |
| Eisai Inc. | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Morphosys, US Inc. | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| Exelixis Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Spectrum Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orserdu$120
How this compares
$1,693 in reported general payments places this provider in the 90th percentile of 1,284 hospitalist providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $8,012 |
| Doxycycline Hyclate | 22 | $103 |
| Methylprednisolone | 13 | $69 |
| Atorvastatin Calcium | 11 | $58 |
| Amlodipine Besylate | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Baytown
- Rody Bou ChaayaBaytown$6K
- Daniel NguyenBaytown$4K
- Sarah SmileyAustin$19.9M
- Ingela Danielsson-SandenMcAllen$5.9M
- Nitendra AgarwalSan Antonio$3.5M
- James TaylorBrownwood$2.8M
- Bingnan ZhangHouston$524K
- Sayyed JaffriStafford$434K
- Jan KemnadeHouston$360K
- Kenechukwu EnekebeCorpus Christi$311K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.